These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 22351749)
1. Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma. Estrada-Bernal A; Palanichamy K; Ray Chaudhury A; Van Brocklyn JR Neuro Oncol; 2012 Apr; 14(4):405-15. PubMed ID: 22351749 [TBL] [Abstract][Full Text] [Related]
2. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Zhang L; Wang H; Ding K; Xu J Toxicol Lett; 2015 Jul; 236(1):43-59. PubMed ID: 25939952 [TBL] [Abstract][Full Text] [Related]
3. FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors. Kiyota M; Kuroda J; Yamamoto-Sugitani M; Shimura Y; Nakayama R; Nagoshi H; Mizutani S; Chinen Y; Sasaki N; Sakamoto N; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M Apoptosis; 2013 Nov; 18(11):1437-1446. PubMed ID: 23851982 [TBL] [Abstract][Full Text] [Related]
4. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275 [TBL] [Abstract][Full Text] [Related]
5. PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. Zheng T; Meng X; Wang J; Chen X; Yin D; Liang Y; Song X; Pan S; Jiang H; Liu L J Cell Biochem; 2010 Sep; 111(1):218-28. PubMed ID: 20506484 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation. Potteck H; Nieuwenhuis B; Lüth A; van der Giet M; Kleuser B Cell Physiol Biochem; 2010; 26(1):67-78. PubMed ID: 20502006 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. Omar HA; Chou CC; Berman-Booty LD; Ma Y; Hung JH; Wang D; Kogure T; Patel T; Terracciano L; Muthusamy N; Byrd JC; Kulp SK; Chen CS Hepatology; 2011 Jun; 53(6):1943-58. PubMed ID: 21391227 [TBL] [Abstract][Full Text] [Related]
8. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis. Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235 [TBL] [Abstract][Full Text] [Related]
9. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219 [TBL] [Abstract][Full Text] [Related]
10. Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720. Hiestand PC; Rausch M; Meier DP; Foster CA Prog Drug Res; 2008; 66():361, 363-81. PubMed ID: 18416311 [TBL] [Abstract][Full Text] [Related]
11. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2. Yoshino T; Tabunoki H; Sugiyama S; Ishii K; Kim SU; Satoh J Cell Mol Neurobiol; 2011 Oct; 31(7):1009-20. PubMed ID: 21519925 [TBL] [Abstract][Full Text] [Related]
12. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Brinkmann V Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729 [TBL] [Abstract][Full Text] [Related]
13. FTY720 modulates human oligodendrocyte progenitor process extension and survival. Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267 [TBL] [Abstract][Full Text] [Related]
14. FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway. Zhang L; Wang H; Zhu J; Ding K; Xu J Tumour Biol; 2014 Nov; 35(11):10707-14. PubMed ID: 25070489 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM. Tomicic MT; Meise R; Aasland D; Berte N; Kitzinger R; Krämer OH; Kaina B; Christmann M Oncotarget; 2015 Oct; 6(32):33755-68. PubMed ID: 26418950 [TBL] [Abstract][Full Text] [Related]
16. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
18. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide. Zhang L; Wang H Pharmacol Rep; 2017 Dec; 69(6):1186-1193. PubMed ID: 29128799 [TBL] [Abstract][Full Text] [Related]
19. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide. López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736 [TBL] [Abstract][Full Text] [Related]
20. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway. Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]